Published in
American Society for Clinical Investigation, Journal of Clinical Investigation, 10(129), p. 4451-4463, 2019
DOI: 10.1172/jci126091
Links
Tools
Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6 blockade–refractory idiopathic multicentric Castleman disease
Journal article published in 2019 by
David C. Fajgenbaum 
,
Ruth-Anne Langan ,
Alberto Sada Japp,
Helen L. Partridge ,
Sheila K. Pierson ,
Amrit Singh ,
Daniel J. Arenas ,
Jason R. Ruth,
Christopher S. Nabel,
Katie Stone,
Mariko Okumura,
Anthony Schwarer,
Fábio Freire Jose,
Nelson Hamerschlak ,
Gerald B. Wertheim
and other authors.
,
Ruth-Anne Langan ,
Alberto Sada Japp,
Helen L. Partridge ,
Sheila K. Pierson ,
Amrit Singh ,
Daniel J. Arenas ,
Jason R. Ruth,
Christopher S. Nabel,
Katie Stone,
Mariko Okumura,
Anthony Schwarer,
Fábio Freire Jose,
Nelson Hamerschlak ,
Gerald B. Wertheim
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 